Founded in 1998 USP has become a leading expert in the development, implementation and management of commercial strategies and supply chain solutions.
All members of the USP team are leading specialists in their own field, handpicked for their professional expertise and experience as well as their personal qualities.
The Commercial Team
Paul Johnson - Business Development
With over 20 years pharmaceutical industry experience Paul brings a wealth of commercial brand management, sales and business development expertise. He has held an array of senior management positions working for Smithkline Beecham, Janssen-Cilag, AstraZeneca, and a number of small speciality value add generic companies. Areas of expertise include, PI and generic defence, product aquisitions, divestitures, licensing and mature brand promotional campaigns.
Margaret Doyle - Director of Business Intelligence
Margaret joined USP in November 2004 as Commercial Manager, having been in the industry for 8 years working first for Ivax as Telesales Manager and then Taro Pharmaceuticals as their UK Manager, having responsibility for the UK office, Commercial and Business Development. More recently Margaret has moved to the position of Business Intelligence Director within USP
Tanya Monteith - Director Tanya has more than 10 years experience in the Pharmaceutical Industry coming through the ranks of shortline wholesale. Tanya joined USP in February 2007 as National Account Manager working her way up to Director of Sales. With this background Tanya has been able to gain a thorough understanding of the pharmaceutical supply chain and also has a clear understanding of the issues faced by manufacturers, which has proved to be advantageous in her more recent role heading up the CLARITYdtp project.
Matt Upton - Non Executive Director Matt has spent the last 15 years as a corporate financier in the various professional services organizations, latterly as a partner at Ernst & Young. Matt joined the USP team in September 2010 to support the executive team in corporate development strategy and finance, particularly around the launch of CLARITYdtp.